None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children aged 12-18 months of either gender and no longer exclusively breastfed Weight to length Z (WLZ) less than 2 SD and greater than or equal to 3 SD without bilateral pedal oedema. Parent(s) willing to study participation and aid in following study procedures. Agree to remain in the study area for the study duration.
Exclusion criteria
Exclusion criteria: Any ongoing fever or medical condition persisting for more than the last 14 days or requires hospitalization. Any congenital/acquired disorder affecting growth. Severe anaemia (less than 8mg/dl) will be assessed by Hemocue. Antibiotic use (within the last 15 days before the onset of intervention) Ongoing maternal antibiotic usage for breastfeeding infants. Receiving concurrent treatment for another condition.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gut microbiome configuration (relative abundance, and alpha and beta diversity)Timepoint: At baseline, directly after intervention and three months after intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Levels of faecal short-chain fatty acids (acetate, propionate and butyrate)Timepoint: At the end of the one-month intervention;Anthropometry indices (weight for length (WLZ), weight for age (WAZ), length for age (LAZ)) and Mid upper arm circumferenceTimepoint: At baseline, immediately after the one-month intervention, and three months post-intervention | — |
Countries
India
Contacts
Christian Medical College Vellore, Tamil Nadu, India